A RET double mutation in the germline of a kindred with FMTC
- PMID: 10826520
- DOI: 10.1055/s-2000-5806
A RET double mutation in the germline of a kindred with FMTC
Abstract
Activating germline mutations of the RET proto-oncogene are found in more than 90% of families with multiple endocrine neoplasia type 2a (MEN 2a) and familial medullary thyroid carcinoma (FMTC). The majority of patients with these hereditary tumors carry germline mutations that result in the substitution of one of five cysteine residues in exon 10 and 11. Different mutations in exons 13, 14 and 15 affecting non-cysteine residues have also been described but are considered to be rare. We now for the first time report a double mutation of the RET proto-oncogene occurring in the germline of a kindred with FMTC. Both mutations occur within the tyrosine kinase domain in exon 14 and lead to the substitution of valine 804 by methionine and arginine 844 by leucine. Since the double mutated allele cosegregated with the disease and was not identified in 200 unrelated normal probands, we conclude that they represent mutations that predispose the individual to the development of FMTC with a mild phenotype.
Comment in
-
A patient with MEN 2 and multiple mutations of RET in the germline.Exp Clin Endocrinol Diabetes. 2000;108(8):493. doi: 10.1055/s-2000-11001. Exp Clin Endocrinol Diabetes. 2000. PMID: 11149622 No abstract available.
Similar articles
-
Familial medullary thyroid carcinoma: not a distinct entity? Genotype-phenotype correlation in a large family.Am J Med. 1996 Dec;101(6):635-41. doi: 10.1016/s0002-9343(96)00330-0. Am J Med. 1996. PMID: 9003111
-
Penetrance of inherited medullary thyroid carcinoma and genotype-phenotype correlation in a large multiple endocrine neoplasia type 2A family with C634Y RET mutation.Endocr Pathol. 2003 Spring;14(1):71-80. doi: 10.1385/ep:14:1:71. Endocr Pathol. 2003. PMID: 12746565
-
Mutation analysis of the RET proto-oncogene in Dutch families with MEN 2A, MEN 2B and FMTC: two novel mutations and one de novo mutation for MEN 2A.Hum Genet. 1996 Jan;97(1):11-4. doi: 10.1007/BF00218825. Hum Genet. 1996. PMID: 8557249
-
RET proto-oncogene mutations in multiple endocrine neoplasia type 2 and medullary thyroid carcinoma.Horm Res. 1997;47(4-6):168-78. doi: 10.1159/000185461. Horm Res. 1997. PMID: 9167949 Review.
-
[From gene to disease; from the RET gene to multiple endocrine neoplasia types 2A and 2B, sporadic and familial medullary thyroid carcinoma, Hirschsprung disease and papillary thyroid carcinoma].Ned Tijdschr Geneeskd. 2001 Nov 17;145(46):2217-21. Ned Tijdschr Geneeskd. 2001. PMID: 11757244 Review. Dutch.
Cited by
-
Paternal age effect mutations and selfish spermatogonial selection: causes and consequences for human disease.Am J Hum Genet. 2012 Feb 10;90(2):175-200. doi: 10.1016/j.ajhg.2011.12.017. Am J Hum Genet. 2012. PMID: 22325359 Free PMC article. Review.
-
Management of hereditary medullary thyroid carcinoma.Endocrine. 2016 Jul;53(1):7-17. doi: 10.1007/s12020-016-0873-1. Epub 2016 Feb 2. Endocrine. 2016. PMID: 26839093 Review.
-
Multiple endocrine neoplasia type 2.Fam Cancer. 2005;4(1):25-36. doi: 10.1007/s10689-005-0656-y. Fam Cancer. 2005. PMID: 15883707 Review.
-
[Hereditary thyroid cancer].Chirurg. 2008 Nov;79(11):1017-28. doi: 10.1007/s00104-008-1558-y. Chirurg. 2008. PMID: 18818894 Review. German.
-
Tandem Germline RET Mutations in a Family Pathogenetic for Multiple Endocrine Neoplasia 2B, Confirmed by a Natural Experiment.Eur Thyroid J. 2014 Dec;3(4):272-7. doi: 10.1159/000369134. Epub 2014 Dec 3. Eur Thyroid J. 2014. PMID: 25759805 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
